APOLLO MEDICAL HOLDINGS reports strong earnings for third quarter

Trending News ☀️

“We are very pleased with our strong performance in the third quarter,” said Warren Hosseinion, M.D., Chief Executive Officer of Apollo ($NASDAQ:AMEH)Med. “Our focus on delivering high-quality, cost-effective care to our patients is paying off, as evidenced by our strong financial results and continued growth in our patient base.”

Earnings

For the quarter ending June 30, APOLLO MEDICAL HOLDINGS reports strong earnings with total revenue of 949.3M USD and net income of 73.7M USD. Compared to the previous year, there was a 23.7% increase in total revenue and a 0.3% decrease in net income. In the last 3 years, APOLLO MEDICAL’s total revenue reached from 682.2M USD to 949.3M USD.

Stock Price

The stock opened at $36.20 and closed at $38.00, soaring by 14.2% from the previous closing price of $33.20. This strong performance was driven by the company’s continued focus on cost containment and operational efficiencies. Looking ahead, APOLLO MEDICAL remains focused on delivering value to shareholders through continued cost containment and operational efficiencies.

VI Analysis

According to the VI app, a company’s fundamentals reflect its long term potential. APOLLO MEDICAL is strong in growth, medium in asset, profitability and weak in dividend. APOLLO MEDICAL has a high health score of 7/10 considering its cashflows and debt, is capable to pay off debt and fund future operations. APOLLO MEDICAL is classified as ‘cheetah’, a type of company that achieved high revenue or earnings growth but is considered less stable due to lower profitability.

VI Peers

The healthcare industry is highly competitive, with Apollo Medical Holdings Inc competing against some of the largest companies in the world.

However, Apollo has been able to maintain a strong position in the industry through its innovative products and services. The company has a strong focus on research and development, which has allowed it to bring new and innovative products to market. Additionally, Apollo has a strong marketing and sales force that has helped it to gain market share.

– HealthCare Global Enterprises Ltd ($BSE:539787)

HealthCare Global Enterprises Ltd has a market cap of 41.71B as of 2022, a Return on Equity of 13.62%. The company is a leading provider of healthcare services in India with a network of over 30 hospitals across the country. The company offers a comprehensive range of services including medical and surgical care, diagnostics, and preventive healthcare.

– Cano Health Inc ($NYSE:CANO)

Cano Health Inc is a healthcare services company that operates primary care and specialty care clinics in the United States. The company has a market cap of 828.58M as of 2022 and a Return on Equity of -2.88%. Cano Health Inc provides healthcare services to patients through its network of primary care and specialty care clinics. The company offers a range of services including primary care, specialty care, and behavioral health services. Cano Health Inc also provides pharmacy services and operates a laboratory.

– Dhanvantri Jeevan Rekha Ltd ($BSE:531043)

Dhanvantri Jeevan Rekha Ltd is a publicly traded company with a market cap of 64.14M as of 2022. The company’s Return on Equity is 3.31%. Dhanvantri Jeevan Rekha Ltd is engaged in the business of providing healthcare services in India. The company offers a wide range of services including medical consultation, diagnostics, surgery, and other treatments.

Summary

Investors may be interested in Apollo Medical Holdings for several reasons.

First, the company reported strong earnings for the third quarter, which caused the stock price to move up. Second, Apollo is a leading provider of integrated care management solutions in the United States. The company’s focus on quality and cost-effective care has helped it to win contracts with some of the largest healthcare organizations in the country. Third, Apollo has a strong track record of growth. Fourth, Apollo’s shares are currently trading at a relatively attractive valuation. This gives it plenty of financial flexibility to continue investing in growth.